Pfizer Inc. (PFE)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Pfizer Inc. (PFE) is up 4.1% since the beginning of the year. At $25 per share, PFE is trading 12.8% below its 52-week high of $29. Investors who bought $1,000 worth of PFE shares 5 years ago would now be looking at an investment worth $830.

Pfizer Inc. (PFE) has returned 4.10% so far this year and 11.94% over the past 12 months. Over the last ten years, PFE has returned 1.96% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Jun 1, 1972, PFE's average daily return is +0.05%, while the average monthly return is +0.96%. At this rate, an investment would double in approximately 6.0 years.

Historically, 54% of months were positive and 46% were negative. The best month was Oct 1974 with a return of +39.7%, while the worst month was Oct 1987 at -24.0%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.

On a daily basis, PFE closed higher 46% of trading days. The best single day was Nov 5, 2021 with a return of +10.9%, while the worst single day was Oct 19, 1987 at -17.3%.

Pfizer Inc. has an annualized alpha of 4.65%, beta of 0.85, and R2 of 0.29 versus S&P 500 Index. Calculated based on daily prices since June 01, 1972.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (83.58%) than losses (78.17%) - typical of diversified or defensive assets.
• R2 of 0.29 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PFE ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

Pfizer Inc. provided a 6.86% dividend yield over the last twelve months, with an annual payout of $1.72 per share. The company has been increasing its dividends for 15 consecutive years.

The table displays the monthly dividend distributions for Pfizer Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Pfizer Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Pfizer Inc. was 69.24%, occurring on Mar 2, 2009. Recovery took 1186 trading sessions.

The current Pfizer Inc. drawdown is 48.02%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Pfizer Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Pfizer Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.